Knockdown of NCK1-AS1 inhibits the development of atherosclerosis by targeting miR-1197/COX10 axis
Authors:
Open Access
- 5 January 2022
- journal article
- research article
- Published by Springer Nature in Journal of Biological Engineering
- Vol. 16 (1) , 1-9
Abstract
Background: Although long non-coding RNA (lncRNA) NCK1-AS1 plays important roles in human cancer, its function in atherosclerosis (AS) remains unclear.Method: The expression of NCK1-AS1 in AS blood samples was detected by qRT-PCR. Oxidized low-density lipoprotein (ox-LDL) was used to construct the AS cell model, and quantitative real-time polymerase chain reaction (qRT-PCR) assay was used to evaluate NCK1-AS1 level. Cell phenotypes including proliferation and apoptosis were assessed by Cell Counting Kit-8 (CCK-8) assay and flow cytometer, respectively. The malondialdehyde level was measured to evaluate oxidative stress. The expression of apoptosis-related proteins was evaluated by western blot. The expression of inflammatory cytokines (IL-1β, IL-6 and TNK-α) was measured by qRT-PCR and ELISA assays. The relationship among NCK1-AS1, miR-1197 and COX10 was determined by bioinformatic analysis and luciferase reporter assay.Results: NCK1-AS1 was significantly upregulated in AS blood samples and ox-LDL stimulated vascular smooth muscle cells (VSMCs). Knockdown of NCK1-AS1 increased cell viability, reduced cell apoptosis and MDA level, and also inhibited the expression of inflammatory cytokines (IL-1β, IL-6 and TNK-α) in ox-LDL stimulated VSMCs. NCK1-AS1 could positively regulate COX10 expression by directly sponging miR-1197. Moreover, co-transfection of sh-NCK1-AS1 and miR-1197 inhibitor, or co-transfection of sh-NCK1-AS1 and pc-COX10 (COX10 overexpressing plasmid) obviously reduced cell viability, promoted cell apoptosis, and increased MDA level in VSMCs followed by ox-LDL treatment for 24 h compared to that in sh-NCK1-AS1 transfected VSMCs.Conclusion: Our study revealed that knockdown of NCK1-AS1 attenuated the development of AS by regulating miR-1197/COX10 axis, suggesting that this lncRNA might be a potential therapeutic target for AS.Keywords
This publication has 30 references indexed in Scilit:
- Long noncoding RNAs and atherosclerosisAtherosclerosis, 2016
- Long Noncoding RNA: Recent Updates in AtherosclerosisInternational Journal of Biological Sciences, 2016
- Antioxidant and anti-inflammatory effects of flavocoxid in high-cholesterol-fed rabbitsNaunyn-Schmiedeberg's Archives of Pharmacology, 2015
- Competing endogenous RNA interplay in cancer: mechanism, methodology, and perspectivesTumor Biology, 2015
- Ox-LDL induces endothelial cell apoptosis via the LOX-1-dependent endoplasmic reticulum stress pathwayAtherosclerosis, 2014
- MicroRNAs and AtherosclerosisCurrent Atherosclerosis Reports, 2013
- Molecular Mechanisms of Long Noncoding RNAsMolecular Cell, 2011
- [Protective effects of autophagy against oxidized LDL-induced injury in endothelial cells].2010
- Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences, 2007
- COX and cancerQJM: An International Journal of Medicine, 2005